Feature | Cardiovascular Business | December 18, 2007 | Dave Fornell

Don’t Overlook the Simple Questions When Purchasing New Technology


Common sense is probably the biggest factor to use as a guide when looking to buy new medical technology and equipment. However, sometimes emotions, territorial department heads, old-school resistance to change and personal preferences influence or override the decision-making process in any profession. To overcome these issues, the basis for any medical evaluation committee should make it a priority to answer one central question: What is best for the patient?

When I attended the 2007 American Society of Anesthesiologists annual meeting in San Francisco in October, I listened in on a refresher course for evaluating new technology, presented by John Abenstein, M.D., Department of Anesthesiology at the Mayo Clinic, Rochester, Minn.

He said committees need to establish criteria for evaluating new technology. The key questions include: Does the technology work, what studies confirm its effectiveness, can the technology work in a real-life situation as opposed to a clinical research facility and will it make clinically relevant differences in outcomes?

A committee should consider if the old equipment still has technical support and if spare parts are available. Will the new equipment do more and will it save time and money? What problem is the new technology going to solve? Dr. Abenstein suggests visiting the factory to see how the devices are made. Is the factory clean and organized? If not, he questions the quality of the machines.

He says to figure in the stability of a company. If a company is not in business three years after you purchase equipment, it will not help your long-term use of the equipment.

All sorts of justifications will be used to sway people to believe new technology is needed. Dr.Abenstein said people should not buy into emotional appeals that the technology is needed for children's or women’s health or else the hospital will not be supporting those causes. He says the bottom line is to ask if the new technology works and if it will significantly improve outcomes and be cost effective.

Some will argue equipment is needed to meet a regulatory mandate. If that argument is used, committees should ask to see the mandate in writing. Dr. Abenstein said many times it is not a mandate, but rather a suggested guideline.

Committees should also look at patient safety issues and consider standardization as a goal. If a hospital uses numerous types of machines for the same function it can lead to errors due to confusion between the different operabilities, or people not knowing how to use a machine they are not used to.
 

Related Content on the Basics of Evaluating New Technology

The Basics for Evaluating New Technology

Four Key Themes Emerging in the Medical Technology Market

Drawing the Line When Evaluating Cost vs. Benefit


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now